RT @FarmaciaOesteAP: (Circulation) 2017 ACC/AHA/HFSA Actualización de la guía de insuficiencia cardíaca. https://t.co/kJzVNo5IFA
RT @FarmaciaOesteAP: (Circulation) 2017 ACC/AHA/HFSA Actualización de la guía de insuficiencia cardíaca. https://t.co/kJzVNo5IFA
RT @FarmaciaOesteAP: (Circulation) 2017 ACC/AHA/HFSA Actualización de la guía de insuficiencia cardíaca. https://t.co/kJzVNo5IFA
(Circulation) 2017 ACC/AHA/HFSA Actualización de la guía de insuficiencia cardíaca. https://t.co/kJzVNo5IFA
RT @DrDanAugustine: ARNI (e.g valsartan/ sacubitril) given class 1 recommendation for use in HFrEF https://t.co/QeyopTeKL8 #CardioEd https…
ARNI (e.g valsartan/ sacubitril) given class 1 recommendation for use in HFrEF https://t.co/QeyopTeKL8 #CardioEd https://t.co/IApb0B6uL9
RT @Med_interna: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart… https://t.co/zbwE9G9eCs #heal…
Download App https://t.co/7PfSndvgrB 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Ma... https://t.co/qb9flTHU5A
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
RT @edgarvlermamd: Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2Psw…
Drugs commonly used for HFrEF from @American_Heart @ACCCardioEd @HFSA #Nephpearls #Cardiorenal 👉🏼 https://t.co/nAoD2PswSA https://t.co/K9gUG9IUaZ
Intravenous iron to improve health status is recommended for symptomatic patients with HF and iron deficiency. https://t.co/ZFltMgNxne
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of #HeartFailure:… https://t.co/UTv64VLIyo | via @CircAHA
ACC/AHA Heart Failure Guideline Update. https://t.co/q4fbyEEs4J
2017 Update to Heart Failure Management Guidelines using BNP by @ACCinTouch, @ahahospitals, @HFSA. Click https://t.co/4zavAMytna
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @Far_HUG: #UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
#UpdateHUG Actualización en el Manejo de IC 💔📚 #heartfailure2017 ACC/AHA/HFSA https://t.co/hz4gQ8cPy3 https://t.co/r8OpuuW1VE
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
RT @ederhernandezmd: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM…
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure https://t.co/LcJfM3Psmu #MedInternaHUN
For HFpEF patients, SBP and DBP should be controlled and diuretics should be used for volume overload. https://t.co/ElEwm1lSOI
To use ivabradine, patients should be optimized on all goal-directed therapies and HR must be 70 or higher. https://t.co/ElEwm14hXa
Ivabradine can be considered for patients with symptomatic HF who are receiving BB at maximum tolerated doses. https://t.co/ElEwm1lSOI
ARNI should NOT be administered to patients with history of angioedema https://t.co/ElEwm1lSOI
Remember that ARNI should NOT be administered concomitantly with ACE inhibitor or within 36 hours of last dose https://t.co/ElEwm1lSOI
RT @AlanaziZaid: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: https://t.co/xlvdeHgR…
RT @ValleAlfonso: Update 17 of ACCF/AHA Guideline for the Management of Heart Failure 2013 via @CircAHA https://t.co/lyGuvpH9GC. @secardio…
RT @AlanaziZaid: 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: https://t.co/xlvdeHgR…
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: https://t.co/xlvdeHgRJv
In patients with chronic HF who tolerate ACE inhibitor or ARB, ARNI replacement is recommended to decrease mortality https://t.co/ElEwm14hXa
Clinical strategy of inhibiting the RAAS system is recommended in combination with BB and aldosterone antagonists https://t.co/ElEwm1lSOI
Clinical strategy of inhibition of RASS (ACEI, ARB, OR Angiotensin II receptor blocker neprilysin inhibitor - ARNI) https://t.co/ElEwm14hXa
New 2017 Heart failure guidelines https://t.co/QzPKvMhmDT
RT @ATRIUMRx: Hot off the press! For 2017, a focus update on HF guidelines from ACC/AHA/HFSA. Will review highlights this week! https://t.c…
RT @ATRIUMRx: Hot off the press! For 2017, a focus update on HF guidelines from ACC/AHA/HFSA. Will review highlights this week! https://t.c…
RT @ATRIUMRx: 2017 HF guidelines: suggest natriuretic peptide biomarker screening and early intervention to prevent HF. https://t.co/ElEwm1…
2017 HF guidelines: suggest natriuretic peptide biomarker screening and early intervention to prevent HF. https://t.co/ElEwm1lSOI
Hot off the press! For 2017, a focus update on HF guidelines from ACC/AHA/HFSA. Will review highlights this week! https://t.co/ElEwm14hXa
RT @GuidelineCent: ACC/AHA/HFSA releases update of their Heart Failure Guidelines, including a new algorithm for treatment. https://t.co/e…
RT @jvillacastin: Actualización de las guías americanas de insuficiencia cardiaca. https://t.co/dSxbmYJvuB https://t.co/9sYMUMZK9u
RT @Profammf: Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/W…
Updated ACC/AHA Heart Failure Guideline now available. Download PDF: https://t.co/m79ltDQy0P via @American_Heart
RT @Profammf: Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/W…
Updated Guidelines for management Heart Failure 2017 https://t.co/M1ZVkB3swU
Updated Guidelines of Heart Failure AHA https://t.co/M1ZVkB3swU
RT @Profammf: Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/W…
RT @Profammf: Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/W…
Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/WYgMLnjbrv
Insuficiencia Cardíaca: ¿Medís el péptido natriurético? El Colegio Americano de Cardiología, junto con la... https://t.co/zzJRN0sw9D
RT @jvillacastin: Actualización de las guías americanas de insuficiencia cardiaca. https://t.co/dSxbmYJvuB https://t.co/9sYMUMZK9u
RT @UMIPIC: [#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvaro…
RT @UMIPIC: [#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvaro…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @UMIPIC: [#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvaro…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @UMIPIC: [#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvaro…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @UMIPIC: [#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvaro…
[#SEMITuit] Objetivos para el tto de HTA en IC @jopesilver @ResidentesSEMI @Sociedad_SEMI @joseansatue @ZapateroAntonio @alvarogfranco https://t.co/cZPzyOeQoz
RT @ASHPOfficial: ACC, AHA, and HFSA have updated their heart failure management guidelines, https://t.co/np63UOUlrd
RT @ASHPOfficial: ACC, AHA, and HFSA have updated their heart failure management guidelines, https://t.co/np63UOUlrd
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @mendez_bailon: Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https:…
RT @ASHPOfficial: ACC, AHA, and HFSA have updated their heart failure management guidelines, https://t.co/np63UOUlrd
Nuevos objetivos de tratamiento de la #hipertension en I.cardiaca: TAS<130 mmHG @SEHLELHA140_90 #SEMItuit @semfyc https://t.co/WTFFLwJIQe https://t.co/LqN6V8LOwP
RT @JosepComin: Focus Update HF Guidelines (USA)... ya nos hablan de iron deficiency!! https://t.co/0Qs10vBdlH
ACC, AHA, and HFSA have updated their heart failure management guidelines, https://t.co/np63UOUlrd
RT @JosepComin: Focus Update HF Guidelines (USA)... ya nos hablan de iron deficiency!! https://t.co/0Qs10vBdlH